Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Henry Schein, Inc. (NASDAQ: HSIC) is set to host its inaugural in-person THRIVE LIVE™ event from April 7-9 at the Bellagio Hotel & Casino in Las Vegas, NV. This premier educational gathering will focus on the latest in dental technology, offering clinicians and their teams opportunities to learn from industry leaders and network with peers. The event will also integrate the Business of Dentistry conference, enhancing the educational value for attendees. The initiative underscores Henry Schein's commitment to equipping dental professionals with vital knowledge for effective practice management.
Henry Schein, a leading provider of healthcare solutions, will release its fourth quarter and full-year 2021 financial results on February 15, 2022, prior to market opening. A live webcast of the earnings call will begin at 10:00 a.m. ET, featuring speeches from executives including CEO Stanley M. Bergman and CFO Steven Paladino. The call will be accessible via the company's webcast link. Henry Schein operates globally, supporting over 1 million customers with a comprehensive range of healthcare solutions.
Henry Schein, Inc. (NASDAQ: HSIC) announced the retirement of CFO Steven Paladino, effective April 29, 2022, after 35 years with the company. Ronald N. South, currently Vice President of Corporate Finance, will succeed him. Paladino will remain on the Board of Directors and serve as an advisor post-retirement. Under Paladino's leadership, the company experienced significant growth, achieving a compound annual growth rate of approximately 12% in net sales and earnings per share since going public in 1995. The transition aims to ensure continuity in financial management.
Henry Schein, the leading provider of healthcare solutions for dental and medical practitioners, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 9:45 a.m. Eastern time. The event will be accessible via live webcast on Henry Schein's investor relations website. As a FORTUNE 500 Company and member of the S&P 500 index, Henry Schein reported sales of $10.1 billion in 2020, with a consistent compound annual growth rate of 12% since going public in 1995. For additional details, visit their website.
Henry Schein, Inc. (Nasdaq: HSIC) announced that CEO Stanley M. Bergman received an award from The National Hispanic Foundation for his efforts in promoting health equity for Hispanic communities. The recognition occurred during the 18th Annual New York Hispanic Health Professional Student Scholarship Gala. Bergman emphasized the company's commitment to reducing health disparities and improving access to healthcare. Over three decades, Henry Schein has partnered with organizations to foster diversity in healthcare and support the recruitment of Hispanic professionals.
Summary not available.
Henry Schein (NASDAQ: HSIC) has signed a cooperative contract with OMNIA Partners to enhance procurement access for K-12, higher education, and healthcare sectors. This agreement includes a master contract with the University of California, facilitating medical supply distribution to eligible public agencies. The offerings include point-of-care diagnostic testing, PPE, and various medical products. The contract aims to streamline procurement, increase savings, and improve health services accessibility for students and staff.
Summary not available.
Henry Schein (NASDAQ: HSIC) has donated over $100,000 to TeamSmile, a non-profit providing dental care to underserved children. This year alone, the company contributed $30,000 in cash, nearly $40,000 in dental supplies, and $25,000 for practice management software training. Since 2007, donations have reached approximately $1 million. TeamSmile has served over 40,000 children, offering over $17 million in free dental care. The remaining TeamSmile event for 2021 will be held at Mercedes-Benz Stadium in Atlanta, GA.
Henry Schein has appointed Scott Serota, former President and CEO of Blue Cross Blue Shield Association, to its Board of Directors effective immediately. Serota, who expanded BCBSA's membership from 65 million to over 100 million, is expected to contribute his healthcare expertise to advance the company's strategic goals. Meanwhile, Barry Alperin will retire from the Board in May, adhering to the director resignation policy upon reaching 80 years of age. This change aims to bolster leadership and a focus on public health challenges.